US 12410430
Modulating apolipoprotein (A) expression
granted A61KA61K31/7125A61K9/0019
Quick answer
US patent 12410430 (Modulating apolipoprotein (A) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/7125, A61K9/0019, A61K9/08, A61P